24-hour ambulatory blood pressure monitoring and hypertension related risk among HIV-positive and HIV-negative individuals: Cross sectional study findings from rural Uganda.

[1]  H. Tweya,et al.  24-H-AMBULATORY BLOOD PRESSURE MONITORING IN HIV(+) - INDIVIDUALS IN SUB-SAHARAN AFRICA , 2019, Journal of Hypertension.

[2]  E. Valadas,et al.  Cardiovascular risk in HIV-infected individuals: A comparison of three risk prediction algorithms. , 2019, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[3]  M. Petersen,et al.  Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study , 2019, BMC Public Health.

[4]  P. Drain,et al.  Integrating hypertension screening at the time of voluntary HIV testing among adults in South Africa , 2019, PloS one.

[5]  G. Gottlieb,et al.  Increasing prevalence of hypertension among HIV-positive and negative adults in Senegal, West Africa, 1994-2015 , 2018, PloS one.

[6]  Wondimye Ashenafi,et al.  Magnitude and associated factors of diabetes mellitus and hypertension among adult HIV-positive individuals receiving highly active antiretroviral therapy at Jugal Hospital, Harar, Ethiopia , 2018, HIV/AIDS.

[7]  G. Bloomfield,et al.  Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms , 2018, Hypertension.

[8]  W. Elmadhoun,et al.  Diabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: re-emerging challenges not to be forgotten , 2017, HIV/AIDS.

[9]  Patrick A Ryscavage,et al.  Prevalence of Systemic Hypertension Among HIV-Infected and HIV-Uninfected Young Adults , 2017, Open Forum Infectious Diseases.

[10]  N. Levitt,et al.  High prevalence of “non-dipping” blood pressure and vascular stiffness in HIV-infected South Africans on antiretrovirals , 2017, PloS one.

[11]  Xinguang Chen,et al.  Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis. , 2017, Journal of the American Society of Hypertension : JASH.

[12]  M. J. van der Laan,et al.  Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa , 2017, JAMA.

[13]  L. Smeeth,et al.  Ecological Study of HIV Infection and Hypertension in Sub-Saharan Africa: Is There a Double Burden of Disease? , 2016, PloS one.

[14]  E. Mills,et al.  Trends and level of control of hypertension among adults attending an ambulatory HIV clinic in Kampala, Uganda: a retrospective study , 2016, BMJ Global Health.

[15]  Ashutosh Kumar Singh,et al.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.

[16]  O. Uthman,et al.  Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis , 2016, Journal of Human Hypertension.

[17]  M. Petersen,et al.  Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda , 2016, PloS one.

[18]  S. Oparil,et al.  Ambulatory Blood Pressure Monitoring in Individuals with HIV: A Systematic Review and Meta-Analysis , 2016, PloS one.

[19]  R. Walker,et al.  Ambulatory Blood Pressure Monitoring to Assess the White‐Coat Effect in an Elderly East African Population , 2015, Journal of clinical hypertension.

[20]  Evelyn P Whitlock,et al.  Diagnostic and Predictive Accuracy of Blood Pressure Screening Methods With Consideration of Rescreening Intervals: A Systematic Review for the U.S. Preventive Services Task Force , 2015, Annals of Internal Medicine.

[21]  Geoffrey A Head,et al.  European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. , 2014, Journal of hypertension.

[22]  N. Levitt,et al.  Ambulatory blood pressure profiles in a subset of HIV-positive patients pre and post antiretroviral therapy , 2014, Cardiovascular journal of Africa.

[23]  L. Smeeth,et al.  Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis , 2013, International journal of epidemiology.

[24]  V. Triant Cardiovascular Disease and HIV Infection , 2013, Current HIV/AIDS Reports.

[25]  K. Kraemer,et al.  HIV infection and the risk of acute myocardial infarction. , 2013, JAMA internal medicine.

[26]  G. Pucci,et al.  Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study , 2013, Journal of hypertension.

[27]  T. Bärnighausen,et al.  Hypertension and Obesity in Adults Living in a High HIV Prevalence Rural Area in South Africa , 2012, PloS one.

[28]  Jianyun Wu,et al.  Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta‐analysis , 2012, HIV medicine.

[29]  C. Tremblay,et al.  Association Between HIV Infection, Antiretroviral Therapy, and Risk of Acute Myocardial Infarction: A Cohort and Nested Case–Control Study Using Québec's Public Health Insurance Database , 2011, Journal of acquired immune deficiency syndromes.

[30]  P. Tebas,et al.  Aging and HIV Infection: A Comparison Between Older HIV-Infected Persons and the General Population , 2010, HIV clinical trials.

[31]  Anne L. Taylor,et al.  Coronary heart disease in HIV-infected individuals. , 2003, Journal of acquired immune deficiency syndromes.

[32]  HIV and AIDS in East and Southern Africa regional overview , 2018 .

[33]  W. Elliott,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2008 .

[34]  W. El-Sadr,et al.  Can the Success of Hiv Scale-up Advance the Global Chronic Ncd Agenda? Differing Global Responses to Hiv and Ncd , 2022 .